Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance

Schmoelzer, Isabella; Wascher, Thomas C.
January 2006
Cardiovascular Diabetology;2006, Vol. 5, p9
Academic Journal
Background: Impaired glucose tolerance (IGT) is associated with increased cardiovascular risk. The pathophysiological mechanisms linking post-challenge hyperglycemia to accelerated atherosclerosis, however remain to be elucidated. Methods: A prospective, open, randomised, cross-over study was performed to investigate the effect of 2 mg repaglinide on hyperglycemia and endothelial function during an oral glucose tolerance test (75 g glucose) in 12 subjects with diagnosed IGT. Blood samples for determination of plasma glucose were drawn fasting, 1 and 2 hours after glucose ingestion. Endothelial function was assessed by measuring flow-mediated dilatation (FMD) of the brachial artery with highresolution ultrasound. Results: Administration of repaglinide resulted in a significant reduction of plasma glucose at 2 hours (172.8+/-48.4 vs. 138.3+/-41.2 mg/dl; p < 0.001). The flow-mediated dilatation (FMD) 2 hours after the glucose-load was significantly reduced in comparison to fasting in the control group (6.21+/-2.69 vs. 7.98+/-2.24 %; p = 0.028), whereas after theadministration of repaglinide the FMD was not significantly different to fasting values (7.24+/-2.57 vs. 8.18+/-2.93 %; p = n.s.). Linear and logistic regression analysis revealed that only the change of glucose was significantly correlated to the change of FMD observed (p < 0.001). Regression analysis after grouping for treatment and time confirmed the strong negative association of the changes of plasma glucose and FMD and indicate that the effect of repaglinide observed is based on the reduction glycemia. Conclusion: In subjects with IGT, the endothelial dysfunction observed after a glucose challenge is related to the extent of hyperglycemia. Reduction of hyperglycemia by repaglinide reduces endothelial dysfunction in a glucose dependent manner.


Related Articles

  • Counterpoint: The Oral Glucose Tolerance Test Is Superfluous. Davidson, Mayer B. // Diabetes Care;Oct2002, Vol. 25 Issue 10, p1883 

    Argues against the use of oral glucose tolerance tests in clinical medicine. Suggestion that the test does not provide information that cannot be obtained by other means; Use of the test to diagnose impaired glucose tolerance or diabetes; Risk factors for cardiovascular disease, including...

  • Hemoglobin A1c, Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes. HONG WANG; SHARA, NAWAR M.; LEE, ELISA T.; DEVEREUX, RICHARD; CALHOUN, DARREN; DE SIMONE, GIOVANNI; UMANS, JASON G.; HOWARD, BARBARA V. // Diabetes Care;Sep2011, Vol. 34 Issue 9, p1952 

    OBJECTIVE--We compared A1C and fasting plasma glucose (FPG) in predicting cardiovascular disease (CVD) in a population with widespread obesity and diabetes. RESEARCH DESIGN AND METHODS--A total of 4,549 American Indian adults underwent the Strong Heart Study (SHS) baseline examination...

  • Impaired Fasting Glucose and Cardiovascular Disease. Perry, Ivan J. // Diabetes Care;Nov99, Vol. 22 Issue 11, p1919 

    Comments on the study conducted by Tominaga et al on impaired fasting glucose and cardiovascular diseases which was published in an issue of `Diabetes Care.' Weaknesses of the study; Importance of avoiding debate on the relative merits of different systems for classification and diagnosis of...

  • Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans. Meyer, Christian; Pimenta, Walkyria; Woerle, Hans J.; Van Haeften, Timon; Szoke, Ervin; Gerich, John; Mitrakou, Asimina // Diabetes Care;Aug2006, Vol. 29 Issue 8, p1909 

    OBJECTIVE -- To compare the pathophysiology of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in a more comprehensive and standardized fashion than has hitherto been done. RESEARCH DESIGN AND METHODS -- We studied 21 individuals with isolated IFG (IFG/normal glucose...

  • Diabetic non-ketotic hyperglycemia and the hemichorea-hemiballism syndrome: A report of four cases. Shalini, B.; Salmah, W.; Tharakan, J. // Neurology Asia;Jun2010, Vol. 15 Issue 1, p89 

    Diabetes mellitus is a common affliction. Although the routine diagnosis and treatment of diabetes are quite familiar to medical personnel, it occasionally presents with some unusual manifestations, one such being the hemichorea-hemiballismus syndrome. We report four non-ketotic hyperglycemic...

  • Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Walker, M.; Mari, A.; Jayapaul, M. K.; Bennett, S. M. A.; Ferrannini, E. // Diabetologia;Dec2005, Vol. 48 Issue 12, p2470 

    Aims/hypothesis: The aim of this prospective study was to investigate predictors of deteriorating glucose tolerance in subjects of British extraction. Methods: A total of 156 non-diabetic subjects (86 with a family history of type 2 diabetes) underwent a 75-g OGTT and anthropometric assessment...

  • Point: A Glucose Tolerance Test Is Important for Clinical Practice. Tuomilehto, Jaakko // Diabetes Care;Oct2002, Vol. 25 Issue 10, p1880 

    Focuses on the importance of glucose tolerance tests in clinical practice. Report that asymptomatic diabetes increases the risk of cardiovascular disease and all-cause mortality; Determination of hyperglycemia; Discussion of screening for blood glucose among high risk patients; Problems with...

  • Pharmacies 'should offer diabetes test'  // Pulse;5/3/2004, Vol. 64 Issue 18, p8 

    Reports that most general physicians want pharmacies to offer blood tests for diagnosing type-2 diabetes in Great Britain. Suitability of pharmacies to conduct diagnostic tests for diabetes.

  • P042 - EVALUATION OF DIFFERENT OGTT REQUESTS. YILMAZ, Gülsen; FİDANCI, Vildan; KILINÇ, Aytün Ş.; SÜRER, Hatice; ÖĞÜŞ, Elmas; YÜCEL, Doğan // Turkish Journal of Biochemistry / Turk Biyokimya Dergisi;2012 Special Issue, Vol. 37 Issue S1, p183 

    Introduction: Oral Glucose Tolerans Test (OGTT) is a test which have different approaches in its application time and method. In 1997, an International Expert Committee of ADA published new classification and diagnostic criteria of diabetes, which were based on the 1979 publication of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics